Your browser doesn't support javascript.
loading
Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation.
Cappato, Riccardo; Ezekowitz, Michael D; Klein, Allan L; Camm, A John; Ma, Chang-Sheng; Le Heuzey, Jean-Yves; Talajic, Mario; Scanavacca, Maurício; Vardas, Panos E; Kirchhof, Paulus; Hemmrich, Melanie; Lanius, Vivian; Meng, Isabelle Ling; Wildgoose, Peter; van Eickels, Martin; Hohnloser, Stefan H.
Afiliación
  • Cappato R; Arrhythmia and Electrophysiology Center, University of Milan, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.
  • Ezekowitz MD; The Sidney Kimell Medical College at Thomas Jefferson University, 1999 Sproul Rd, Suite 25, Broomall, PA 19008, USA michael.ezekowitz@comcast.net.
  • Klein AL; Department of Cardiovascular Medicine, Cleveland Clinic Heart and Vascular Institute, Cleveland, OH, USA.
  • Camm AJ; Division of Clinical Sciences, St George's, University of London, London, UK.
  • Ma CS; Cardiology Division, Beijing AnZhen Hospital, Capital Medical University, Beijing, China.
  • Le Heuzey JY; Division of Cardiology and Arrhythmology, Hôpital Européen Georges Pompidou, Université Paris V René-Descartes, Paris, France.
  • Talajic M; Department of Medicine, Research Center, Montreal Heart Institute, Université de Montréal, Montreal, Canada.
  • Scanavacca M; Arrhythmia Clinical Unit of Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil.
  • Vardas PE; Department of Cardiology, Heraklion University Hospital, Heraklion (Crete), Greece.
  • Kirchhof P; Centre for Cardiovascular Sciences, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK SWBH NHS Trust, Birmingham, UK Department of Cardiovascular Medicine, Hospital of the University of Münster, Münster, Germany.
  • Hemmrich M; Global Medical Affairs, Bayer HealthCare, Berlin, Germany.
  • Lanius V; Global Research and Development Statistics, Bayer HealthCare, Berlin, Germany.
  • Meng IL; Global Medical Affairs, Bayer HealthCare, Berlin, Germany.
  • Wildgoose P; Janssen Scientific Affairs, LLC, Raritan, NJ, USA.
  • van Eickels M; Global Medical Affairs, Bayer HealthCare, Berlin, Germany.
  • Hohnloser SH; Department of Cardiology, Division of Clinical Electrophysiology, J.W. Goethe University, Frankfurt, Germany.
Eur Heart J ; 35(47): 3346-55, 2014 Dec 14.
Article en En | MEDLINE | ID: mdl-25182247
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Tiofenos / Vitamina K / Cardioversión Eléctrica / Morfolinas / Inhibidores del Factor Xa Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Heart J Año: 2014 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Tiofenos / Vitamina K / Cardioversión Eléctrica / Morfolinas / Inhibidores del Factor Xa Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Heart J Año: 2014 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido